Results 81 to 90 of about 7,222 (160)

CoronaVac or BNT162b2 Vaccine as a Third Dose

American Journal of Respiratory and Critical Care Medicine, 2022
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
openaire   +2 more sources

Incidence Rate/1 M doses symptoms of AE Sinovac/CoronaVac reported on vaccine safety website.

, 2023
Incidence Rate/1 M doses symptoms of AE Sinovac/CoronaVac reported on vaccine safety website.
Bernie Endyarni Medise (4112032), Nastiti Kaswandani (11755563), Julitasari Sundoro (10035770), Hindra Irawan Satari (4112035), Elcha Leonard (17137982), Sri Rezeki Harun Hadinegoro (17137985), Ade Putra (17137988), Putra Fajar Angkasa (17137991)   +7 more
core   +1 more source

Humoral immune response characterization of heterologous prime- boost vaccination with CoronaVac and BNT162b2 [PDF]

, 2022
Publicado en: Vaccine, 2022, 40(35):5189-5196. DOI 10.1016/j.vaccine.2022.07.023Background: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has proven to be a successful strategy for prevent severe infections.

core  

Erythema multiforme after CoronaVac vaccination

Journal of the European Academy of Dermatology and Venereology, 2021
N.T. Lopes, C.E.O. Pinilla, A.C. Gerbase
openaire   +3 more sources

Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac

The SARS-CoV-2 Omicron variant and its sublineages continue to cause COVID-19-associated pediatric hospitalizations, severe disease, and death globally. BNT162b2 and CoronaVac are the main vaccines used in Chile.
Díaz-Samirin, Michal, Pablo Díaz, Sette, Alessandro, Heriberto E. García-Escorza, Alba Grifoni, Escobar, Daniel F., Vasquez, Abel E., Grifoni, Alba, Puentes, Rodrigo, Díaz, Janepsy, Nicolás A. Muena, Cárdenas-Cáceres, Simone, Natalia T. Santis-Alay, Michal Díaz-Samirin, Barra, Gisselle, Diego A. Díaz-Dinamarca, Cecilia Canales, Díaz, Pablo, Simone Cárdenas-Cáceres, Gisselle Barra, Janepsy Díaz, Santis-Alay, Natalia T., Alessandro Sette, García-Escorza, Heriberto E., Canales, Cecilia, Díaz-Dinamarca, Diego A., Daniel F. Escobar, Nicole D. Tischler, Abel E. Vasquez, Muena, Nicolás A., Tischler, Nicole D., Rodrigo Puentes   +31 more
core   +1 more source

Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination [PDF]

Clinical Rheumatology, 2021
T. Oskay, M. Isık
openaire   +2 more sources

Sobre a eficácia da CoronaVac no Twitter

Liinc em Revista
CoronaVac, developed in Brazil by the Butantan Institute in partnership with Sinovac, remained amid the political disputes that permeated the way our country faced the COVID-19 pandemic. In order to map and understand, in a limited period, the conversations surrounding the effectiveness of the said immunizer on the social networking site Twitter, the ...
Carina Luisa Ochi Flexor, Gustavo Costa, Vitória Lobo Batista Barros   +2 more
openaire   +2 more sources

Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study

Background: The evidence of SARS-CoV-2 vaccine effectiveness in people living with HIV (PLWH) is limited. This study evaluated the humoral immune response to CoronaVac™ (virus inactivated) and BNT162b2 (mRNA- based) vaccines in PLWH and HIV-negative ...
Vial Cox, María Cecilia, Silva, Macarena, Canals, Andrea, Hormazabal, Juan, Cortes Salinas, Lina Jimena, Charpentier, Paulo, Wolff, Marcelo   +6 more
core   +1 more source

Lichen planus after CoronaVac: a rare complication of vaccines [PDF]

Journal of the European Academy of Dermatology and Venereology, 2022
A. Satılmış Kaya, N. Cemşitoğlu, E. Adışen, Ö. Erdem   +3 more
openaire   +3 more sources

Cutaneous reactions after CoronaVac and BioNTech vaccines

Journal of Cosmetic Dermatology, 2022
Ümran Öner, Akın Aktaş
openaire   +3 more sources